postmenopausal women metabolic syndrome postmenopausal metabolic syndrome
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Postmenopausal women who agreed to include in the study Age between 45 and 65 years More than 1 year since her last period Menopause at ≥ 45 years old by natural or surgical menopause Diagnosed metabolic syndrome, according to the National Cholesterol Education Program, Adult Treatment Panel III (NCEP ATP III) : ≥ 3 / 5 (Abdominal obesity [≥ 80 cm for women; criteria for Asian population], Hypertriglyceridemia [≥ 150 mg/dL], Low HDL cholesterol [ 130/ 85 mmHg or use of antihypertensive agent], High fasting glucose [≥ 100 mg/dL] or use of hypoglycemic agents
Exclusion criteria
Exclusion criteria: Taking hormone replacement therapy > 6 months Taking medication for osteoporosis Taking steroid more than 3 months Rheumatoid arthritis Thyroid disease or thyroid functional abnormality Malignancy, ESRD, immune deficiency, cardiovascular failure Cerebrovascular disease/ dementia Psychiatric disease Difficult to communicate due to disability
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| bone mineral density of postmenopausal women who had MS and non-MS at the time of recruitment DXA scan | — |
Secondary
| Measure | Time frame |
|---|---|
| the association of each components of MS and BMD at analysis Multiple linear regression | — |
Countries
Thailand
Contacts
Faculty of Medicine, Khon Kaen University